Intrinsic Value of S&P & Nasdaq Contact Us

Lisata Therapeutics, Inc. LSTA NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
45/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — LSTA

Lisata Therapeutics, Inc. (LSTA) has a market capitalization of $36.22M and trades at $4.01. The 52-week range is 1.81-5.07.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.1, Earnings Per Share (EPS) of $-1.91, annual revenue of $170K.

The stock has a beta of 1.11, operates in the Healthcare sector.

Trading Data
Current Price$4.01
52-Week Range1.81-5.07
Volume223.24K
Avg Volume (30D)182.06K
Market Cap$36.22M
Beta (1Y)1.11
Company
IPO Date1999-03-01
Employees26
CEODavid J. Mazzo
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS1280583022
CUSIP128058302
Income (Latest Year)
Revenue$170K
Gross Profit$24K
EBITDA$-18.06M
Operating Income$-18.21M
Net Income$-16.59M
EPS$-1.91
EPS Diluted$-1.91
Shares Outstanding$8.69M
Balance Sheet (Latest Year)
Total Assets$17.74M
Current Assets$17.7M
Cash & ST Investments$15.96M
Total Liabilities$3.14M
Net Debt$-15.96M
Total Equity$14.6M
Valuation Ratios
P/E Ratio-2.1
P/S Ratio213.06
P/B Ratio2.48
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message